Nuvation Bio Inc. Class A Common Stock vs Yum China Holdings Inc — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B), while Yum China Holdings Inc trades at $42.88 (market cap $14.11B). The key difference: Yum China Holdings Inc is far larger — about 8.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Yum China Holdings Inc pays a 2.78% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Yum China Holdings Inc for 77 Days on average.
| NUVB | YUMC | |
|---|---|---|
Market Cap | $1.74B | $14.11B |
Volume | 9,289,619 | 2,350,650 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.54 | $57.95 |
52-Week Low | $3.41 | $39.98 |
Typical Hold Time | 1 Days | 77 Days |
Enterprise Value | $1.33B | $15.02B |
Dividend Yield | — | 2.78% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YUMC trades at $42.92, up 5.58% today, with strong analyst support (73.68% buy ratings) but technical indicators show bearish momentum. The company demonstrates solid fundamentals with consistent revenue growth from $9.6B in 2022 to $11.8B in 2025, and net income improving to $929M. Recent strategic moves include the $1.2B acquisition of Pizza Hut China brand ownership and expansion of Pizza Hut Burger Bars to 300 locations.
YUMC presents a value opportunity with reasonable valuation (P/E 15.3, P/S 1.2) and strong profitability (ROE 17.5%), though technical weakness and China economic exposure pose near-term risks. The stock's 25.6% analyst upside potential and consistent earnings beats support long-term growth prospects despite current bearish technical signals.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →